Recon: Trump reportedly eying Martin Makary to lead FDA; Novartis acquires Kate Therapeutics for up to $1.1B

Recon

ReconJason Scott

Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States